| Drug Name: | Tulobuterol hydrochloride (56776-01-3) |
|---|---|
| PubChem ID: | 5702285 |
| SMILES: | CC(C)(C)NCC(C1=CC=CC=C1Cl)O.Cl |
| InchiKey: | RSLNRVYIRDVHLY-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 264.196 |
| LogP | : | 3.1833 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 32.26 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Desensitization Cardiovascular Effects | Beta-2 adrenergic receptor (P07550) | Bronchodilatation@ susceptibility to agonist-induced desensitization@cardiovascular effects. [ ADR Type 1 ] | Beta2-adrenergic receptor genetics |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|